nodes	percent_of_prediction	percent_of_DWPC	metapath
Clonazepam—GABRA3—Graves' disease	0.707	1	CbGaD
Clonazepam—CYP2E1—Methimazole—Graves' disease	0.163	0.767	CbGbCtD
Clonazepam—CYP3A4—Methimazole—Graves' disease	0.0494	0.233	CbGbCtD
Clonazepam—Pigmentation disorder—Methimazole—Graves' disease	0.00784	0.133	CcSEcCtD
Clonazepam—Pigmentation disorder—Propylthiouracil—Graves' disease	0.00667	0.113	CcSEcCtD
Clonazepam—Ageusia—Methimazole—Graves' disease	0.00323	0.0546	CcSEcCtD
Clonazepam—Ageusia—Propylthiouracil—Graves' disease	0.00275	0.0464	CcSEcCtD
Clonazepam—Lymphadenopathy—Methimazole—Graves' disease	0.00223	0.0376	CcSEcCtD
Clonazepam—GABRB2—GABA A receptor activation—GABRA3—Graves' disease	0.00192	0.123	CbGpPWpGaD
Clonazepam—Lymphadenopathy—Propylthiouracil—Graves' disease	0.00189	0.032	CcSEcCtD
Clonazepam—GABRG2—GABA A receptor activation—GABRA3—Graves' disease	0.00176	0.113	CbGpPWpGaD
Clonazepam—GABRA1—GABA A receptor activation—GABRA3—Graves' disease	0.00154	0.0985	CbGpPWpGaD
Clonazepam—Drowsiness—Methimazole—Graves' disease	0.00146	0.0247	CcSEcCtD
Clonazepam—Neuropathy peripheral—Methimazole—Graves' disease	0.00144	0.0243	CcSEcCtD
Clonazepam—Drowsiness—Propylthiouracil—Graves' disease	0.00125	0.021	CcSEcCtD
Clonazepam—Neuropathy peripheral—Propylthiouracil—Graves' disease	0.00122	0.0206	CcSEcCtD
Clonazepam—GABRB2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00118	0.0755	CbGpPWpGaD
Clonazepam—Alopecia—Methimazole—Graves' disease	0.00116	0.0196	CcSEcCtD
Clonazepam—Haemoglobin—Propylthiouracil—Graves' disease	0.00112	0.019	CcSEcCtD
Clonazepam—Haemorrhage—Propylthiouracil—Graves' disease	0.00112	0.0189	CcSEcCtD
Clonazepam—GABRG2—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.00108	0.069	CbGpPWpGaD
Clonazepam—Vertigo—Methimazole—Graves' disease	0.00103	0.0174	CcSEcCtD
Clonazepam—Leukopenia—Methimazole—Graves' disease	0.00102	0.0173	CcSEcCtD
Clonazepam—Alopecia—Propylthiouracil—Graves' disease	0.000988	0.0167	CcSEcCtD
Clonazepam—Myalgia—Methimazole—Graves' disease	0.000974	0.0165	CcSEcCtD
Clonazepam—Arthralgia—Methimazole—Graves' disease	0.000974	0.0165	CcSEcCtD
Clonazepam—GABRA1—Ligand-gated ion channel transport—GABRA3—Graves' disease	0.000941	0.0603	CbGpPWpGaD
Clonazepam—Oedema—Methimazole—Graves' disease	0.000934	0.0158	CcSEcCtD
Clonazepam—Thrombocytopenia—Methimazole—Graves' disease	0.000914	0.0155	CcSEcCtD
Clonazepam—Vertigo—Propylthiouracil—Graves' disease	0.000874	0.0148	CcSEcCtD
Clonazepam—Leukopenia—Propylthiouracil—Graves' disease	0.000871	0.0147	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Methimazole—Graves' disease	0.000851	0.0144	CcSEcCtD
Clonazepam—Somnolence—Methimazole—Graves' disease	0.00083	0.014	CcSEcCtD
Clonazepam—Myalgia—Propylthiouracil—Graves' disease	0.000828	0.014	CcSEcCtD
Clonazepam—Arthralgia—Propylthiouracil—Graves' disease	0.000828	0.014	CcSEcCtD
Clonazepam—Dyspepsia—Methimazole—Graves' disease	0.000822	0.0139	CcSEcCtD
Clonazepam—Oedema—Propylthiouracil—Graves' disease	0.000794	0.0134	CcSEcCtD
Clonazepam—Thrombocytopenia—Propylthiouracil—Graves' disease	0.000778	0.0131	CcSEcCtD
Clonazepam—Urticaria—Methimazole—Graves' disease	0.000742	0.0125	CcSEcCtD
Clonazepam—Body temperature increased—Methimazole—Graves' disease	0.000738	0.0125	CcSEcCtD
Clonazepam—Musculoskeletal discomfort—Propylthiouracil—Graves' disease	0.000724	0.0122	CcSEcCtD
Clonazepam—Somnolence—Propylthiouracil—Graves' disease	0.000706	0.0119	CcSEcCtD
Clonazepam—Dyspepsia—Propylthiouracil—Graves' disease	0.000699	0.0118	CcSEcCtD
Clonazepam—Pruritus—Methimazole—Graves' disease	0.000661	0.0112	CcSEcCtD
Clonazepam—ALB—Binding and Uptake of Ligands by Scavenger Receptors—SCGB3A2—Graves' disease	0.000641	0.0411	CbGpPWpGaD
Clonazepam—Urticaria—Propylthiouracil—Graves' disease	0.000631	0.0107	CcSEcCtD
Clonazepam—Body temperature increased—Propylthiouracil—Graves' disease	0.000628	0.0106	CcSEcCtD
Clonazepam—GABRB2—GABA receptor activation—GABRA3—Graves' disease	0.000625	0.04	CbGpPWpGaD
Clonazepam—Vomiting—Methimazole—Graves' disease	0.000594	0.01	CcSEcCtD
Clonazepam—Rash—Methimazole—Graves' disease	0.000589	0.00995	CcSEcCtD
Clonazepam—Dermatitis—Methimazole—Graves' disease	0.000588	0.00994	CcSEcCtD
Clonazepam—Headache—Methimazole—Graves' disease	0.000585	0.00989	CcSEcCtD
Clonazepam—GABRG2—GABA receptor activation—GABRA3—Graves' disease	0.000571	0.0366	CbGpPWpGaD
Clonazepam—Pruritus—Propylthiouracil—Graves' disease	0.000562	0.0095	CcSEcCtD
Clonazepam—Bromazepam—GABRA3—Graves' disease	0.000558	0.088	CrCbGaD
Clonazepam—Nausea—Methimazole—Graves' disease	0.000555	0.00938	CcSEcCtD
Clonazepam—Clorazepate—GABRA3—Graves' disease	0.000507	0.0799	CrCbGaD
Clonazepam—Vomiting—Propylthiouracil—Graves' disease	0.000505	0.00853	CcSEcCtD
Clonazepam—Rash—Propylthiouracil—Graves' disease	0.000501	0.00846	CcSEcCtD
Clonazepam—Dermatitis—Propylthiouracil—Graves' disease	0.0005	0.00845	CcSEcCtD
Clonazepam—GABRA1—GABA receptor activation—GABRA3—Graves' disease	0.000499	0.032	CbGpPWpGaD
Clonazepam—Headache—Propylthiouracil—Graves' disease	0.000497	0.00841	CcSEcCtD
Clonazepam—Clotiazepam—GABRA3—Graves' disease	0.000486	0.0766	CrCbGaD
Clonazepam—Nausea—Propylthiouracil—Graves' disease	0.000472	0.00797	CcSEcCtD
Clonazepam—Alprazolam—GABRA3—Graves' disease	0.000459	0.0724	CrCbGaD
Clonazepam—Quazepam—GABRA3—Graves' disease	0.000445	0.0702	CrCbGaD
Clonazepam—Flunitrazepam—GABRA3—Graves' disease	0.000421	0.0662	CrCbGaD
Clonazepam—Estazolam—GABRA3—Graves' disease	0.000393	0.062	CrCbGaD
Clonazepam—Halazepam—GABRA3—Graves' disease	0.000382	0.0602	CrCbGaD
Clonazepam—Nitrazepam—GABRA3—Graves' disease	0.00038	0.0598	CrCbGaD
Clonazepam—Fludiazepam—GABRA3—Graves' disease	0.000371	0.0584	CrCbGaD
Clonazepam—GABRB2—Orphan transporters—GABRA3—Graves' disease	0.000364	0.0234	CbGpPWpGaD
Clonazepam—Prazepam—GABRA3—Graves' disease	0.000362	0.057	CrCbGaD
Clonazepam—Flurazepam—GABRA3—Graves' disease	0.000338	0.0532	CrCbGaD
Clonazepam—Triazolam—GABRA3—Graves' disease	0.000337	0.0531	CrCbGaD
Clonazepam—GABRG2—Orphan transporters—GABRA3—Graves' disease	0.000333	0.0214	CbGpPWpGaD
Clonazepam—Oxazepam—GABRA3—Graves' disease	0.000327	0.0515	CrCbGaD
Clonazepam—Midazolam—GABRA3—Graves' disease	0.000313	0.0493	CrCbGaD
Clonazepam—GABRA1—Orphan transporters—GABRA3—Graves' disease	0.000291	0.0187	CbGpPWpGaD
Clonazepam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000287	0.0184	CbGpPWpGaD
Clonazepam—Diazepam—GABRA3—Graves' disease	0.000268	0.0422	CrCbGaD
Clonazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.000263	0.0168	CbGpPWpGaD
Clonazepam—GABRB2—Ion channel transport—GABRA3—Graves' disease	0.000255	0.0164	CbGpPWpGaD
Clonazepam—GABRG2—Ion channel transport—GABRA3—Graves' disease	0.000234	0.015	CbGpPWpGaD
Clonazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA3—Graves' disease	0.00023	0.0147	CbGpPWpGaD
Clonazepam—GABRB2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000216	0.0138	CbGpPWpGaD
Clonazepam—GABRA1—Ion channel transport—GABRA3—Graves' disease	0.000204	0.0131	CbGpPWpGaD
Clonazepam—GABRG2—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000197	0.0127	CbGpPWpGaD
Clonazepam—GABRA1—Transmission across Chemical Synapses—GABRA3—Graves' disease	0.000173	0.0111	CbGpPWpGaD
Clonazepam—GABRB2—Neuronal System—GABRA3—Graves' disease	0.000165	0.0106	CbGpPWpGaD
Clonazepam—GABRG2—Neuronal System—GABRA3—Graves' disease	0.000151	0.0097	CbGpPWpGaD
Clonazepam—GABRA1—Neuronal System—GABRA3—Graves' disease	0.000132	0.00848	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—GC—Graves' disease	0.000113	0.00721	CbGpPWpGaD
Clonazepam—GABRB2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.89e-05	0.0057	CbGpPWpGaD
Clonazepam—NAT2—Metabolism—B3GNT2—Graves' disease	8.53e-05	0.00547	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—ICAM1—Graves' disease	8.53e-05	0.00547	CbGpPWpGaD
Clonazepam—GABRG2—Transmembrane transport of small molecules—GABRA3—Graves' disease	8.13e-05	0.00521	CbGpPWpGaD
Clonazepam—GABRA1—Transmembrane transport of small molecules—GABRA3—Graves' disease	7.11e-05	0.00456	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—ICAM1—Graves' disease	6.94e-05	0.00445	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IFNG—Graves' disease	6.49e-05	0.00416	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—IL1B—Graves' disease	5.79e-05	0.00371	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—ICAM1—Graves' disease	5.51e-05	0.00353	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IFNG—Graves' disease	5.28e-05	0.00338	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—IL1B—Graves' disease	4.71e-05	0.00302	CbGpPWpGaD
Clonazepam—ALB—Metabolism of lipids and lipoproteins—GC—Graves' disease	4.6e-05	0.00295	CbGpPWpGaD
Clonazepam—ALB—Vitamin B12 Metabolism—TNF—Graves' disease	4.2e-05	0.00269	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IFNG—Graves' disease	4.19e-05	0.00269	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Graves' disease	4.13e-05	0.00265	CbGpPWpGaD
Clonazepam—ALB—Transmembrane transport of small molecules—GABRA3—Graves' disease	4.07e-05	0.00261	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—IL1B—Graves' disease	3.74e-05	0.0024	CbGpPWpGaD
Clonazepam—ALB—Folate Metabolism—TNF—Graves' disease	3.42e-05	0.00219	CbGpPWpGaD
Clonazepam—ALB—Platelet activation, signaling and aggregation—IL2RA—Graves' disease	3.04e-05	0.00195	CbGpPWpGaD
Clonazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Graves' disease	3e-05	0.00192	CbGpPWpGaD
Clonazepam—ALB—Selenium Micronutrient Network—TNF—Graves' disease	2.71e-05	0.00174	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—GC—Graves' disease	2.39e-05	0.00153	CbGpPWpGaD
Clonazepam—ALB—Metabolism—GC—Graves' disease	2.05e-05	0.00131	CbGpPWpGaD
Clonazepam—CYP2E1—Metabolism—B3GNT2—Graves' disease	1.81e-05	0.00116	CbGpPWpGaD
Clonazepam—ALB—Hemostasis—IL2RA—Graves' disease	1.57e-05	0.00101	CbGpPWpGaD
Clonazepam—ALB—Metabolism—B3GNT2—Graves' disease	1.55e-05	0.000996	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—GC—Graves' disease	1.11e-05	0.00071	CbGpPWpGaD
Clonazepam—CYP3A4—Metabolism—B3GNT2—Graves' disease	8.39e-06	0.000538	CbGpPWpGaD
